Evidence map›Paper›PMID 26285699›Full record

ArticleMalaria journal2015

Major decrease in malaria transmission on Mayotte Island.

Olivier Maillard, Tinne Lernout, Sophie Olivier, Aboubacar Achirafi, Lydéric Aubert, Jean François Lepère, Julien Thiria, Frédéric Pagès, Laurent Filleul

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. [Mayotte, a malaria-free island at last?]Medecine tropicale et sante internationale · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Olivier MaillardRegional Office of the French Institute for Public Health Surveillance (InVS), Mayotte, France. olmaillard@yahoo.fr.
Tinne LernoutRegional Office of the French Institute for Public Health Surveillance (InVS), Mayotte, France. tinne.lernout@wiv-isp.be.
Sophie OlivierHospital Centre of Mayotte, Mayotte, France. s.olivier@chmayotte.fr.
Aboubacar AchirafiRegional Health Agency (ARS), Mayotte, France. aboubacar.achirafi@ars.sante.fr.
Lydéric AubertRegional Office of the French Institute for Public Health Surveillance (InVS), Ile De France, France. lyderic.aubert@ars.sante.fr.
Jean François LepèreHospital Centre of Mayotte, Mayotte, France. jf.lepere@chmayotte.fr.
Julien ThiriaRegional Health Agency (ARS), Mayotte, France. julien.thiria@ars.sante.fr.
Frédéric PagèsRegional Office of the French Institute for Public Health Surveillance (InVS), Mayotte, France. frederic.pages@ars.sante.fr.
Laurent FilleulRegional Office of the French Institute for Public Health Surveillance (InVS), Mayotte, France. laurent.filleul@ars.sante.fr.
Institut de Veille Sanitaire · FRAgence Régionale de Santé Ile-de-France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium falciparum is responsible for most malaria cases on Mayotte Island, in the Comorian Archipelago. Malaria is endemic and a major public health problem in the archipelago with an intense, stable and permanent transmission. This study reports results of 8 years of malaria surveillance from 2007 to 2014 after the strengthening of malaria control activities in Mayotte and the neighbouring islands.

methodsSurveillance was based on physicians' reports of malaria cases between January 2007 and December 2014. Malaria cases were confirmed by at least a positive rapid diagnostic test and/or demonstration of Plasmodium sp. in a blood smear. The date, and the patients' age, sex, address, presentation of symptoms, biology, treatment and recent history of travel were collected by verbal questioning during consultation and/or hospitalization. Monthly rainfall data were also compiled during the study period.

resultsFrom 2007 to 2014, 2073 cases were reported on Mayotte Island: 977 imported cases, 807 autochthonous cases and 289 cases of unknown origin. The total malaria annual parasite incidence lowered from 3.0 in 2007 to 0.07 per 1,000 inhabitants in 2014 as the autochthonous malaria incidence decreased from 1.6 to 0.004 per 1,000 inhabitants in the same period and in all age groups. Most of the imported cases came from Comoros (94 %). Severe forms represented approximately 11 % of cases, and only two deaths have been recorded among the imported cases. Approximately 19 % of cases were hospitalized (3 % in an intensive care unit). There is clearly a decrease in malaria transmission in Mayotte since 2007 and the goal of elimination seems more achievable than ever. In 2011, Mayotte entered the elimination phase when P. falciparum API passed under 1 case per 1,000 people at risk.

conclusionsThe combination of vector control measures, active surveillance and case management, including effective treatment with artemisinin-based combination therapy, has been essential to achieve a present status of low and decreasing malaria transmission on the island. Mayotte has entered the elimination phase, but some goals remain to be accomplished before a programme re-orientation toward malaria elimination is contemplated. Moreover, a regional management policy is crucial because this would allow control measures to be targeted and based on a regional surveillance-response system rather than isolated.

Indexed as

AdolescentAdultChildChild, PreschoolComorosFemaleHumansIncidenceInfantInfant, NewbornMalaria, FalciparumMaleMiddle AgedPublic Health SurveillanceRetrospective StudiesYoung Adult

Identifiers

PMID26285699
PMCPMC4545551
OpenAlexW2151882816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.